Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-23

Clinical Trial Update: Safety Study of a Disrupted Adenovirus (Ad) Serotype Cocaine Vaccine for Cocaine-dependent Individuals [Phase 1]

View source ↗

Summary

Phase 1 safety study evaluating a disrupted adenovirus-based cocaine vaccine for individuals with cocaine dependence.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Disrupted Adenovirus Serotype Cocaine Vaccine (cocaine vaccine)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Cocaine Dependence | Phase 1 | Status: RECRUITING